Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers — Stella

Home/Colon Cancer Stage II/Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

View on ClinicalTrials.gov

Recruiting

Back to Colon Cancer Stage II trials

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

651 Dongfeng Road East, Guangzhou, Guangdong

Key details

Phase

Large-scale testing

Sponsor

Sun Yat-sen University

Enrollment target

~840 participants

Started

December 2021

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated January 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.